Form 4: IGM Biosciences Director Strohl Receives 125,000 Restricted Stock Units

Director William Strohl of IGM Biosciences received 125,000 restricted stock units (RSUs) on August 8, 2024, which vest over time based on continued service.

Summary

• William Strohl, a director at IGM Biosciences, received 125,000 restricted stock units (RSUs) on August 8, 2024.
• These RSUs represent a contingent right to receive one share of IGM Biosciences' common stock per RSU.
• The RSUs vest in eight equal installments, starting August 15, 2024, and continuing until April 30, 2026, contingent upon Strohl's continued consulting services to IGM Biosciences.
• Vested RSUs will be delivered on the earlier of the first quarterly release date following Strohl's separation from service (March 12, June 12, September 12, or December 12) or immediately before a change in control of IGM Biosciences.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of RSUs is a standard practice and indicates alignment of interests between the director and the company's shareholders. The vesting schedule incentivizes continued service.

Positives

• The grant of RSUs aligns the director's interests with the long-term success of IGM Biosciences.
• The vesting schedule incentivizes continued service and contribution from the director.

Risks

• The value of the RSUs is dependent on the future stock price of IGM Biosciences, which is subject to market fluctuations and company performance.
• If the director ceases to provide consulting services before all RSUs are vested, the unvested portion will be forfeited.

Future Outlook

The director's continued service is tied to the vesting of the RSUs, suggesting an ongoing commitment to IGM Biosciences.

Industry Context

Granting stock-based compensation to directors is a common practice in the biotechnology industry to align their interests with shareholders and incentivize long-term value creation.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the director's interests with the company's long-term success.
• The director is incentivized to continue providing valuable consulting services to the Issuer.

Key Dates